Webinar Explores Leveraging Prior Knowledge in Cell & Gene Therapy
An upcoming webinar, supported by unspecified partners, will delve into the role of prior knowledge across diverse contexts in cell and gene therapy (CGT) products. The session aims to enhance efficiency, safety, and innovation in the field.
The webinar, produced by GEN, will explore the use of prior knowledge in CGM, nonclinical, clinical, and manufacturing settings. Attendees can expect to learn about valuable data types to share, navigating data leveraging in partnerships, and integrating knowledge across disciplines.
Key themes from the FDA's recent listening session will be discussed. On September 18, 2025, the FDA's Office of Therapeutic Products (OTP) held a public hearing focused on accelerating CGT product development and streamlining reviews. The session highlighted the collaborative roles of developers, regulators, and external partners in using prior knowledge to speed up and improve product development and processing.
Following the presentations, a live Q&A session will allow attendees to interact with a panel of CGT experts. The webinar aims to foster collaboration and innovation in the CGT field by leveraging prior knowledge effectively.
